Department of Orthodontics and Pediatric Dentistry, Faculty of Dentistry, University of São Paulo, São Paulo, Brazil.
Department of Dentistry, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands.
BMC Oral Health. 2024 Jun 13;24(1):687. doi: 10.1186/s12903-024-04417-0.
Recently, trials have supported changes in deep caries management. However, reporting might lack details, affecting interpretation and implementation. Thus, we aimed to evaluate the adherence to the CONSORT statement and the risk of bias of randomized controlled trials (RCTs) on deep caries management published in pediatric dental journals.
We searched PubMed for RCTs in six pediatric dental journals between 2010 and 2022, focusing on deep caries lesion management. Adherence to the CONSORT guideline and the risk of bias were assessed using a modified tool with 19 items; each scored from 0 to 2 (maximum of 38 points), and the Cochrane risk-of-bias (RoB 2) tool. We performed descriptive and regression analyses (α = 5%).
We analyzed 127 RCTs. The mean (standard deviation) CONSORT adherence score was 21.1 (6.7). Notably, 96.1% of the studies received a score of 2 for the "intervention" item, whereas 83.5% scored 0 for the "estimated effect size". The risk of bias assessment revealed that 40.2% of the RCTs were at high risk, 59% were at low risk, and 0.8% were at low risk. RCTs with a high risk of bias had lower CONSORT scores (p<0.001) than those with low or some concerns. RCTs published in journals without the endorsement of the CONSORT statement had lower scores than those in journals with the endorsement of the CONSORT statement. Older RCTs (6-10 years old and more than 10 years old) showed significantly lower CONSORT statement compliance than trials published recently within 5 years.
Adherence to the CONSORT was relatively low among the investigated RCTs. Moreover, lower adherence to the CONSORT was associated with a higher risk of bias.
This study protocol was prospectively registered on the Open Science Framework - DOI ( 10.17605/OSF.IO/V6SYZ ).
最近,试验支持深龋管理方式的改变。然而,报告可能缺乏细节,影响解释和实施。因此,我们旨在评估在儿科牙科期刊上发表的关于深龋管理的随机对照试验(RCT)对 CONSORT 声明的遵守情况和偏倚风险。
我们在 2010 年至 2022 年间在 6 种儿科牙科期刊上搜索了 RCTs,重点关注深龋病变管理。使用一个带有 19 个项目的改良工具评估对 CONSORT 指南的遵守情况和偏倚风险;每个项目的得分从 0 到 2(最高 38 分),以及 Cochrane 偏倚风险(RoB 2)工具。我们进行了描述性和回归分析(α=5%)。
我们分析了 127 项 RCT。CONSORT 遵守评分的平均值(标准差)为 21.1(6.7)。值得注意的是,96.1%的研究在“干预”项目中获得了 2 分,而 83.5%的研究在“估计效果大小”项目中获得了 0 分。偏倚风险评估显示,40.2%的 RCT 处于高风险,59%处于低风险,0.8%处于低风险。高偏倚风险的 RCT 的 CONSORT 评分低于低风险或存在一些问题的 RCT(p<0.001)。没有 CONSORT 声明认可的期刊发表的 RCT 的评分低于有 CONSORT 声明认可的期刊发表的 RCT。6-10 岁和 10 岁以上的 RCT 的 CONSORT 声明遵守率明显低于最近 5 年内发表的试验。
在所调查的 RCT 中,对 CONSORT 的遵守程度相对较低。此外,对 CONSORT 的较低遵守与较高的偏倚风险相关。
本研究方案在开放科学框架上进行了前瞻性注册 - DOI(10.17605/OSF.IO/V6SYZ)。